CASI Pharmaceuticals IncAdd to My Watchlist

CASI:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 1.86
    Last
  • 0.05  -2.62%
    Today's Change
  • 1.91
    Previous Close
  • Today
     
    0.91
    1.99
    52 Week Low - High
8:10 pm ET 9/25/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding60 million
Market Cap$112 million
Return on Equity ttm-62.67%
Last DividendCASI:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.154
EPS: Year Est. 12/17 ttm-0.150
 
EPS: Quarterly Actual 6/17 -0.04
EPS: Quarterly Est. 9/17 -0.04
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate22.73
Company Description
CASI Pharmaceuticals Inc. researches and develops biopharmaceutical products that focus on the role of blood vessels in health and disease. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration.
Revenue$0
Net Income$-9 million
Total Assets$28 million
Employees26
Web Sitewww.casipharmaceuticals.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!